ENElisabeth A. Northam

Elisabeth A. Northam

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Elisabeth A. Northam has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Improving mental health of adolescents with Type 1 diabetes: protocol for a randomized controlled trial of the Nothing Ventured Nothing Gained online adolescent and parenting support intervention

    by Naomi J Hackworth, Jan Matthews, Kylie Burke, Zvezdana Petrovic, Britt Klein, Elisabeth A Northam, Michael Kyrios, Lisa Chiechomski, Fergus J Cameron

    Management of Type 1 diabetes comes with substantial personal and psychological demands particularly during adolescence, placing young people at significant risk for mental health problems. Supportive parenting can mitigate these risks, however the challenges associated with parenting a child with a chronic illness can interfere with a parent’s capacity to parent effectively. Interventions that provide support for both the adolescent and their parents are needed to prevent mental health problems in adolescents; to support positive parent-adolescent relationships; and to empower young people to better self-manage their illness. This paper presents the research protocol for a study evaluating the efficacy of the Nothing Ventured Nothing Gained online adolescent and parenting intervention which aims to improve the mental health outcomes of adolescents with Type 1 diabetes.


  • Predictors of Diabetes Self‐care, Metabolic Control, and Mental Health in Youth with Type 1 Diabetes

    by Naomi J Hackworth, Victoria E Hamilton, Susan M Moore, Elisabeth A Northam, Zvezdana Bucalo, Fergus J Cameron


  • Open Access

    Adolescents with Type 1 Diabetes: parental perceptions of child health and family functioning and their relationship to adolescent metabolic control

    by Susan M Moore, Naomi J Hackworth, Victoria E Hamilton, Elisabeth P Northam, Fergus J Cameron

    Background: Adolescents with Type 1 diabetes (T1D) show less effective metabolic control than other age groups, partly because of biological changes beyond their control and partly because in this period of developmental transition, psychosocial factors can militate against young people upholding their lifestyle and medical regimens. Parents have an important role to play in supporting adolescents to self-manage their disease, but resultant family tensions can be high. In this study, we aimed to assess family functioning and adolescent behaviour/ adjustment and examine the relationships between these parent-reported variables and adolescent metabolic control (HbA1c), self-reported health and diabetes self-care. Method: A sample of 76 parents of Australian adolescents with T1D completed the Child Health Questionnaire –Parent form. Their adolescent child with T1D provided their HbA1c level from their most recent clinic visit, their self-reported general health, and completed a measure of diabetes self-care. Results: Parent-reported family conflict was high, as was disease impact on family dynamics and parental stress. Higher HbA1c (poorer metabolic control) and less adequate adolescent self-care were associated with lower levels of family functioning, more adolescent behavioural difficulties and poorer adolescent mental health. Conclusions: The implication of these findings was discussed in relation to needs for information and support among Australian families with an adolescent with T1D, acknowledging the important dimension of family functioning and relationships in adolescent chronic disease management.


  • Open Access

    Understanding the Diabetic Brain: New Technologies but Old Challenges

    by Elisabeth A. Northam, Fergus J. Cameron

    Does type 1 diabetes damage the developing brain or not? If so, how and when does this occur, and which brain regions are most vulnerable? These questions have come under increasing scrutiny in the last 20 years as improved technologies and greater success in reducing traditional diabetes complications have allowed us to broaden our therapeutic goals. Many (including the authors) would argue that optimal neural ontogeny is the primary developmental task of childhood and adolescence, as this more than anything else defines our adulthood. The brain is not included in that long list of organ systems that can be repaired or transplanted. Thus, arguably the preeminent measure of the impact of any chronic disease is how it may affect the brain. All the more so when that disease disrupts glucose homeostasis and interferes with the brain’s primary metabolic fuel supply. Recent meta-analysis reviews (1,2) have confirmed subtle decrements in overall IQ in children with type 1 diabetes, as well as in specific skills such as attention, information processing speed, and higher-order executive skills, which are most evident in those with early-onset (<5 years of age) disease. Lower academic achievement in children with type 1 diabetes compared with healthy peers highlights the functional implications of these cognitive deficits (3,4). Thus, although there is now reasonable consensus that cognitive deficits do …


  • Open Access

    Central Nervous System Function in Youth With Type 1 Diabetes 12 Years After Disease Onset

    by Elisabeth A. Northam, Debbie Rankins, Ashleigh Lin, R. Mark Wellard, Gaby S. Pell, Sue J. Finch, George A. Werther, Fergus J. Cameron

    OBJECTIVE—In this study, we used neurocognitive assessment and neuroimaging to examine brain function in youth with type 1 diabetes studied prospectively from diagnosis. RESEARCH DESIGN AND METHODS—We studied type 1 diabetic (n = 106) and control subjects (n = 75) with no significant group difference on IQ at baseline 12 years previously by using the Wechsler Abbreviated Scale of General Intelligence, magnetic resonance spectroscopy and imaging, and metabolic control data from diagnosis. RESULTS—Type 1 diabetic subjects had lower verbal and full scale IQs than control subjects (both P < 0.05). Type 1 diabetic subjects had lower N-acetylaspartate in frontal lobes and basal ganglia and higher myoinositol and choline in frontal and temporal lobes and basal ganglia than control subjects (all P < 0.05). Type 1 diabetic subjects, relative to control subjects, had decreased gray matter in bilateral thalami and right parahippocampal gyrus and insular cortex. White matter was decreased in bilateral parahippocampi, left temporal lobe, and middle frontal area (all P < 0.0005 uncorrected). T2 in type 1 diabetic subjects was increased in left superior temporal gyrus and decreased in bilateral lentiform nuclei, caudate nuclei and thalami, and right insular area (all P < 0.0005 uncorrected). Early-onset disease predicted lower performance IQ, and hypoglycemia was associated with lower verbal IQ and volume reduction in thalamus; poor metabolic control predicted elevated myoinositol and decreased T2 in thalamus; and older age predicted volume loss and T2 change in basal ganglia. CONCLUSIONS—This study documents brain effects 12 years after diagnosis in a type 1 diabetic sample whose IQ at diagnosis matched that of control subjects. Findings suggest several neuropathological processes including gliosis, demyelination, and altered osmolarity.


  • Therapy Insight: the impact of type 1 diabetes on brain development and function

    by Elisabeth A Northam, Debbie Rankins, Fergus J Cameron

    The CNS is one of the main organ systems that is affected in type 1 diabetes, as both cerebral glucose and insulin levels are frequently abnormal, even when the diabetes is well-controlled. Literature is emerging that documents pathophysiological CNS changes and neurocognitive deficits in both adults and children with type 1 diabetes, but empirical findings to date have often been inconsistent and difficult to interpret. This article provides a comprehensive review of current knowledge about the impact of type 1 diabetes on brain development and function, focusing particularly on the evidence for specific illness-related risk factors for CNS sequelae. We argue that clinical management of young patients with type 1 diabetes should take into account current knowledge of the relative risks of hypoglycemia and hyperglycemia to the developing brain.


  • Interventions to promote optimal health outcomes in children with Type 1 diabetes—are they effective?

    by E. A. Northam, S. Todd, F. J. Cameron

    The incidence of Type 1 diabetes is increasing worldwide, imposing enormous public health costs, as well as profoundly affecting individual quality of life. There is evidence that psychological problems are increased in children with diabetes and this morbidity is often associated with poor metabolic control. Specific risk factors for this dual morbidity are emerging from empirical studies. The next challenge is to identify effective interventions for use with children at risk for adverse mental and physical health outcomes. The intervention literature is reviewed. It is noted that most studies have used diabetes‐specific, unstandardized interventions in groups of adolescents, with few interventions trialled with younger children. No study has targeted a specific psychological disorder such as behaviour problems or depression, both of which are known to be increased in children with diabetes and for which effective standardized interventions are available. Attention is drawn to methodological limitations in many of the studies conducted to date and suggestions made to reduce these in future interventions attempting to reduce the burden of illness in children with diabetes.


  • Psychiatric morbidity and health outcome in Type 1 diabetes – perspectives from a prospective longitudinal study

    by E. A. Northam, L. K. Matthews, P. J. Anderson, F. J. Cameron, G. A. Werther

    Aims  To describe psychiatric status and relationship to metabolic control in adolescents with Type 1 diabetes studied prospectively from diagnosis.Methods  Adolescents (n = 41) completed a self‐report measure of psychiatric status 10 years after disease onset. Metabolic control information was recorded prospectively from diagnosis. The rate and type of psychiatric disorder were determined and the relationship between mental health status and metabolic control history examined.Results  Thirty‐seven per cent of the adolescents met criteria for a DSM‐IV psychiatric disorder, two to three times higher than community levels of psychiatric morbidity. Females were significantly more likely to receive a diagnoses (χ2 = 4.98, P < 0.05). Two thirds of participants had experienced at least one serious hypoglycaemic episode and one third had a history of chronic poor metabolic control. DSM‐IV diagnoses were present in half of those with a history of chronic poor control, one third of the hypoglycaemia group and one quarter of well controlled participants. Adolescents with a current Mood (t = −2.83, P < 0. 01), Anxiety (t = −3.77, P = 0.001) or Behaviour (t = 2.56, P < 0.05) disorder and those with a history of poorly controlled diabetes (F (2,29) = 5.4, P = 0.01) had higher externalizing behaviour problem scores at diagnosis than those without current disorder.Conclusions  Adolescents with Type 1 diabetes are at high risk for psychiatric disorder. Poorly controlled diabetes over the first 10 years of illness was associated with pre‐existing behaviour problems at diagnosis and there was a trend for an association with current psychiatric status.